Journal article
Could patents interfere with the development of a cardiovascular polypill?
Abstract
BackgroundThe Wellcome Trust, the World Health Organization, and cardiologists have advocated for the idea of a “polypill” containing multiple cardiovascular drugs to be co-formulated into a single pill for over a decade. Some cardiologists have asserted that the drugs commonly considered for inclusion into such a polypill are older and therefore free of patent protection. We tested this assertion. This project was requested by the World Heart …
Authors
Beall RF; Schwalm J-DR; Huffman MD; McCready T; Yusuf S; Attaran A
Journal
Journal of Translational Medicine, Vol. 14, No. 1,
Publisher
Springer Nature
Publication Date
December 2016
DOI
10.1186/s12967-016-0997-3
ISSN
1479-5876